Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Pyxinol ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-A-062-Tuesday
  • By: WANG, Hongbo (Yantai, China)
  • Co-author(s): Jinbo Ma: Key lab of Molecular Pharmacology and drug evaluation , Yantai University, Yantai, China
    Yanting Yang: Key lab of Molecular Pharmacology and drug evaluation, Yantai University, Yantai, China
    Hongbo Wang: Key Lab of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai, China
    Fenghua Fu: Key lab of Molecular Pharmacology and drug evaluation, Yantai University, Yantai, China
  • Abstract:

    Backgrounds

    Cisplatin is a chemotherapeutic agent against solid tumors, however, the cisplatin time- and dose-dependent nephrotoxicity is the main adverse effect of cisplatin. 

    Aims

    In this study, we investigated whether the pyxinol (DQ) had protective effects against cisplatin-induced nephrotoxicity. 

    Methods

    To clarify it, one in vivo model of

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses